As in prior studies,11,14–16 we also observed Her-2 protein overexpression and Her-2 gene amplification in a minority of LGD cases, suggesting the involvement of Her-2 in BE progression to dysplasia and carcinoma. This evidence concerns the gene ERBB2 and carcinoma.